On one side, altered cells follow hyperplasia that evolve toward low-grade tumors, on the other, they become dysplastic (tp53 mutation) and follow the CIS pathway that could evolve toward invasive carcinoma [18]. Here, TP53 is linked to invasive carcinoma.